Biobased Mappain Synthesis of Schweinfurthins G, K, and R
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing schweinfurthins G, K, and R are hindered by a large number of synthetic steps and low yields, making it difficult to access these compounds for pharmacological studies and potential therapeutic applications.
Innovation Solution
A process involving the use of mappain as a biobased precursor, which reduces the number of synthetic steps and improves yield, allowing for the synthesis of schweinfurthins G, K, and R through a four-step process involving protection, epoxidation, cyclization, and deprotection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional chemical synthesis routes are used to obtain schweinfurthins, then the compounds can be produced, but the number of synthetic steps becomes prohibitively large (15-22 steps) and the overall yield becomes extremely low (less than 1%)
Solution Approach 1:
The patent uses mappain as a key intermediary compound that serves as a biobased precursor. By introducing this natural product intermediate, the synthesis route is dramatically shortened from 15-22 steps to just 4 steps, while simultaneously improving the overall yield from less than 1% to 32-40%. This intermediary approach allows the complex schweinfurthin structures to be built upon a pre-formed core structure provided by nature.
Solution Approach 2:
The patent changes the fundamental parameter of the starting material from commercially available synthetic precursors to a biobased natural product (mappain). This parameter change fundamentally transforms the synthesis pathway, reducing both the number of steps and improving yield. The use of renewable biological resources as starting materials is the key parameter change that resolves the technical contradiction.
2Productivity
If extraction from plants is used to obtain schweinfurthins, then the compounds can be obtained, but the yield of extraction is very low and accessibility is poor
Solution Approach 1:
Instead of directly extracting schweinfurthins from plants (which gives low yields), the patent uses mappain as an intermediary that is more abundant in nature. This intermediary is extracted from plant sources and then converted through a short, efficient synthetic sequence to produce schweinfurthins in much higher yields (32-40%), thereby resolving the contradiction between natural source extraction and product accessibility.
Solution Approach 2:
The patent employs a biobased precursor (mappain) that can be obtained from renewable plant sources. By using this readily available natural intermediate rather than attempting direct extraction of the target compounds, the process achieves both sustainability and high productivity, making the synthesis economically viable and scalable.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process significantly enhances the accessibility and yield of schweinfurthins G, K, and R, facilitating the development of novel analogues for pharmacological studies and potential therapeutic agents.
Implementation Method 1
A process involving the use of mappain as a biobased precursor, which reduces the number of synthetic steps and improves yield, allowing for the synthesis of schweinfurthins G, K, and R through a four-step process involving protection, epoxidation, cyclization, and deprotection.
Data Source
AI summary
The present invention relates to a process for preparing at least one schweinfurthin chosen from schweinfurthin G of formula (SW-G), schweinfurthin K of formula (SW-K) and schweinfurthin R of formula (SW-R), characterized in that it comprises a step of using mappain of formula (IV).